Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Androgen Receptor Targeting in Mantle Cell Lymphoma: A Pilot Trial of Enzalutamide

NCT02489123 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT02489123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02489123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Androgen Receptor Targeting in Mantle Cell Lymphoma: A Pilot Trial of Enzalutamide
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Terminated
Start date
August 11, 2015
Completion date
June 16, 2020
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ann arbor stage i mantle cell lymphoma, ann arbor stage ii mantle cell lymphoma, ann arbor stage iii mantle cell lymphoma, ann arbor stage iv mantle cell lymphoma, recurrent mantle cell lymphoma, refractory mantle cell lymphoma